Core42 names Talal M. Al Kaissi as Interim Chief Executive Officer, citing his deep institutional knowledge and strong government and enterprise relationships to steer the company’s next growth phase. Al Kaissi brings extensive operational expertise and long-standing relationships across government…
PureHealth, the Middle East’s largest healthcare group, has launched the UAE’s largest and most advanced AI-powered standalone diagnostic laboratory through its subsidiary, PureLab, marking a major milestone in the country’s diagnostic and precision-medicine capabilities. Spanning 70,000 square feet, the seven-storey…
In cancer research, innovation is often constrained by the tools designed to advance it. When those tools are expensive, complex, or difficult to maintain, progress slows. Researchers at NYU Abu Dhabi have introduced a solution that could remove a long-standing…
The U.S. Food and Drug Administration has granted formal approval to Axogen’s Avance Nerve Graft, a move that secures up to 12 years of potential market exclusivity for the company in the United States. The Avance Nerve Graft, a processed…
Vaccine manufacturers and public health experts are voicing strong concern after a U.S. advisory panel voted to end its long-standing recommendation that all newborns receive a hepatitis B vaccine at birth — a policy shift critics warn could erode decades…
